GlassScriptPhysician profile
Jonathan David Rice
NPI 1518256783
$7,161.23
in general payments reported to CMS, 2019-2025
13 companies · $874 in 2025
The $874 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,916 · 2022: $118 · 2023: $3,928 · 2024: $326 · 2025: $874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $1,338 · Travel and Lodging: $790.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $1,337.78 |
| Travel and Lodging | $790.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,741.92 | 2021-2024 | Ion, Da Vinci Surgical System |
| Atricure, INC. | $686.85 | 2021-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Davol INC. | $171.32 | 2025 | Progel Applicator Spray Tips |
| Depuy Synthes Sales INC. | $124.95 | 2025 | Matrixrib, Zipfix |
| Boston Scientific Corporation | $120.00 | 2021 | |
| Arthrex, INC. | $106.45 | 2025 | |
| Kls-Martin L.P. | $87.94 | 2025 | |
| Zimmer Biomet Holdings, INC. | $36.79 | 2023 | Ribfix Blu Advantage |
| Ethicon US, LLC | $24.54 | 2021 | |
| Novo Nordisk INC | $18.08 | 2022 | |
| Ambu INC. | $17.06 | 2024 | |
| Medtronic, INC. | $13.60 | 2025 | Signia |
| Conmed Corporation | $11.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Rice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.